Winthrop Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Winthrop Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15K	Hold	81	–	–	﹤0.01%	221
2026 Q1	$14K	Hold	81	–	–	﹤0.01%	228
2025 Q4	$14K	Sell	81 -54	-40%	-$8.77K	﹤0.01%	231
2025 Q3	$19K	Sell	135 -82	-38%	-$11.2K	﹤0.01%	200
2025 Q2	$27K	Sell	217 -42	-16%	-$5.16K	0.01%	201
2025 Q1	$33K	Sell	259 -17,216	-99%	-$2.33M	0.01%	175
2024 Q4	$2.3M	Buy	+17,475	New	+$2.46M	0.61%	40
2024 Q1	–	Sell	-19,124	Closed	-$2.6M	–	201
2023 Q4	$2.6M	Buy	+19,124	New	+$2.33M	0.85%	33

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Winthrop Capital Management's IBB Position: Q2 2026 in Review

Winthrop Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 81 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #221.

Winthrop Capital Management first reported a position in IBB in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.6M in Q4 2023. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Winthrop Capital Management held 81 shares of iShares Biotechnology ETF worth $15K as of Q2 2026.
Winthrop Capital Management left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Winthrop Capital Management's portfolio in Q2 2026, its #221 holding.
Winthrop Capital Management first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 8 quarters since.
Winthrop Capital Management's iShares Biotechnology ETF position peaked at $2.6M in Q4 2023.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Winthrop Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.